全国性组织病理学研究反映MRI引入对前列腺癌常规诊疗路径的影响
该研究基于荷兰全国病理数据库2015至2021年127,856例首次诊断性前列腺穿刺活检,评估MRI纳入指南后常规实践中活检结局的变化。结果显示活检总量下降,癌阴性活检比例从49%降至29%,GG≥2检出率从30%升至53%,病理报告中MRI术语占比从8.2%升至51%,活检与根治标本GG一致率从51%升至60%。
要点
- 全国常规实践中癌阴性活检比例由49%降至29%,GG≥2检出率由30%升至53%。
- 病理报告MRI相关术语占比由8.2%升至51%,提示MRI使用增加。
- 活检与根治标本ISUP GG一致率由51%升至60%,诊断准确性改善。
核心结论
- 荷兰全国病理数据显示诊断效率与效能随时间改善,表现为活检量减少、癌阴性活检减少及GG≥2检出增加。
- 上述变化与估计的MRI使用率上升同步,提示MRI驱动的诊断改善。
研究设计与样本
- 回顾性全国性研究,纳入荷兰2015至2021年无既往前列腺癌男性的所有诊断性活检病理报告,取自全国病理数据库Palga。
- 共分析127,856例活检(116,711名男性),以病理报告中MRI相关术语作为MRI使用的替代指标。
- 采用Mann-Kendall检验评估单调时间趋势。
主要发现
- 年诊断性活检数量从2015年18,719例降至2021年17,094例(-8.7%,p=0.13)。
- 癌阴性活检比例从49%降至29%(p=0.003),GG≥2检出率从30%升至53%(p=0.002)。
- GG1检出率轻度下降(20%至18%,p=0.02),病理报告MRI术语占比从8.2%升至51%。
- 活检与根治性前列腺切除标本的ISUP GG一致率从51%升至60%(p=0.007)。
临床怎么用
- 常规临床中MRI引入后前列腺穿刺活检的癌阴性比例下降而高级别癌检出增加,支持MRI用于诊断路径。
- 病理报告MRI术语占比可作为评估MRI在常规实践中渗透度的参考指标。
- 活检与根治标本GG一致率改善提示MRI可能有助于更准确的分级。
局限性
- 分析无法校正机会性PSA筛查增加或辅助诊断工具使用的影响。
- MRI使用以病理报告术语为替代指标,非直接影像记录。
- 为回顾性全国数据库研究,非随机对照设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Magnetic resonance imaging (MRI), introduced into European (2019) and Dutch (2020) guidelines, reshaped prostate cancer (PCa) diagnostics by altering biopsy indications and strategies. In expert-center studies MRI-based diagnostics reduces biopsy rates and ISUP Grade Group (GG) 1 detection, while maintaining or increasing GG ≥ 2 detection compared to systematic biopsies. We evaluated nationwide biopsy outcomes during MRI adoption in routine practice in the Netherlands. METHODS: Retrospective nationwide study of histopathology reports from all diagnostic biopsies in men without prior PCa in the Netherlands (2015-2021), retrieved from the Dutch nationwide pathology databank (Palga). Outcomes included annual biopsy volumes and proportions cancer-negative, GG1 and GG ≥ 2 biopsies. MRI-related terminology served as a proxy for MRI use. ISUP GG concordance between biopsy and radical prostatectomy (RP), defined as identical highest GG in biopsy and RP specimen, was assessed. The Mann-Kendall test evaluated monotonic time trends. RESULTS: Among 127,856 biopsies (116,711 men), annual diagnostic biopsy numbers decreased from 18,719 (2015) to 17,094 (2021; -8.7%, p = 0.13). Cancer-negative biopsies declined from 49% to 29% (p = 0.003), while GG ≥ 2 detection increased from 30% to 53% (p = 0.002). GG1 detection minimally decreased (20% to 18%, p = 0.02). MRI terminology in pathology reports increased (8.2% to 51%) and biopsy-RP GG concordance improved (51% to 60%, p = 0.007). Analyses could not adjust for increased opportunistic PSA screening or adjunct diagnostic tool use. CONCLUSIONS: Nationwide Dutch pathology data show improved diagnostic efficiency and efficacy over time, with fewer biopsies, fewer cancer-negative biopsies, and increased GG ≥ 2 detection. These findings coincide with rising estimated MRI uptake, suggesting MRI-driven diagnostic improvements.
引用
- Prinsen AMA, Slagter S, Schoots IG, et al. A nationwide histopathology study reflecting the impact of the introduction of MRI in the diagnostic trajectory of prostate cancer in routine clinical care. Prostate Cancer Prostatic Dis. 2026. PMID: 42350634. doi:10.1038/s41391-026-01134-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。